Sign up


Match Document Document Title
5863563 Treatment of pulmonary conditions associated with insufficient secretion of surfactant  
Methods and compositions for the treatment of the symptoms of a patient who has a pulmonary condition associated with an inhibition of surfactant secretion by type II alveolar cells are described....
5861431 Incontinence treatment  
The present invention provides a method of treating incontinence in a patient that has a bladder and a urethra. The urethra forms a lumen for draining the bladder. The method comprises the steps of...
5861434 Compositions containing L-carnitine or an acyl L-carnitine in combination with an ace-inhibitor for the treatment of cardiovascular disorders and a method for treating cardiovascular disorders  
Compositions containing (a) L-carnitine, an acyl L-carnitine, or a pharmacologically acceptable salt thereof in combination with (b) an ACE-inhibitor are useful for treating cardiovascular...
5861435 Method for preventing settlement of aquatic fouling organisms  
A method for preventing settlement of aquatic fouling organisms on surface of an aquatic structure without environmental hazard is provided. The method is based upon absolutely novel concept to...
5851537 Topical application of α-DFMO for preventing skin cancer  
A salve includes a water-miscible, hydrophilic cream vehicle, 1-22% by weight a-DFMO, and no absorption enhancer. The salve is preferably contained in an ointment tube permanently sealed at one end...
5852009 Compositions, including pharmaceutical compositions, for inhibiting the advanced glycosylation of proteins, and therapeutic methods based thereon  
The present invention relates to compositions and methods for inhibiting protein aging. Accordingly, a composition is disclosed which comprises an agent or compound capable of inhibiting the...
5847002 Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and NSAID  
The use of:(a) a non-steroidal anti-inflammatory agent,and(b) hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments, and subunits of...
5843997 Excitatory amino acid receptor antagonists  
The present invention provides novel compounds that affect excitatory amino acid receptors and are useful in the treatment of neurological disorders. This invention also provides synthetic methods...
5834516 Meadowfoam betaines in personal care applications  
The present invention deals with the composition of matter and the utilization of certain novel meadowfoam based betaine compounds. These materials are useful in personal care applications.
5834517 Meadowfoam sulfosuccinates in personal care applications  
The present invention deals with a process for cleaning and conditioning hair and skin which comprises the contacting of hair or skin woth an effective concentration of certain novel meadowfoam...
5830919 Method to protect plants from fungal infection  
A method for protecting a crop against fungal diseases by inducing local and systemic resistance of the crop comprising applying to the crop or its locus a composition containing an effective...
5827886 Composition for relief of arthritis-induced symptoms  
A composition and method of using it for ameliorating inflammatory reactions and painful and other symptoms of the diseases of arthritis, lumbago, low back pain, myalgias and neuralgias. The...
5827820 Aqueous peritoneal dialysis solution  
The subject matter of this invention concerns an aqueous peritoneal dialysis solution which is obtained immediately prior to administration from two individual solutions, the first of which...
5824708 Virucidal substances  
The process of reducing the count of a virus by contacting the virus with (1) the reaction product of a) N-substituted propylenediamines corresponding to formula I: R1 --NH--CH2 --CH2 --CH2 --NH2...
5817329 Nutritional supplement for increased muscle size and strength for body builders  
The present invention relates to the method and composition for use of diet supplements by athletes and bodybuilders. A first supplement comprising, the amino acid acetyl-L-Carnitine, in...
5817621 External remedy possessing trophoprotective effect  
A dermatological composition for external use comprising a lipid ointment base, vitamin A, a salicylic acid or a derivative thereof, D-camphor, a biogenic GABAergic substance, a biogenic...
5817695 Nutritional product with high fat, low carbohydrate and amino acid imbalance  
A nutritional product is provided for cancer patients comprising, as per caloric requirement, a low concentration of carbohydrate, a high concentration of fat and an imbalance of amino acids...
5798363 Use for tachykinin antagonists to treat emesis  
The present invention relates to the use of tachykinin antagonists, including substance P antagonists and other neurokinin antagonists, in the treatment of emesis. Also described are novel...
5798371 Pharmaceutical composition endowed with an antialcoholic and nootropic effect  
A pharmaceutical composition having an antialcoholic and nootropic effect which is administered sublingually. The active ingredients of the composition are the amino acid L-threonine or a...
5792796 Methods for treating anxiety and panic  
The instant invention is novel uses of known cyclic amino acids. Such compounds as gabapentin are useful in the treatment of anxiety and in the treatment and/or prevention of panic attacks.
5789443 Method for treating flushing associated with menopause  
A method for treating flushing as a symptom of menopause is disclosed. Specifically, the method comprises administering to a patient in need thereof an effective amount of leucine, or leucine in...
5788958 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders  
The present invention is directed to the use of an inhibitor of NO activity, such as a nitric oxide scavenger or an NO synthase inhibitor, as an antitumor therapy to reduce tumor blood flow and...
5783593 Inhibitors of squalene synthetase and protein farnesyltransferase  
The present invention provides a compound of the formula ##STR1## which inhibit squalene synthetase and cholesterol biosynthesis and are useful in the treatment of e.g., hyperlipidaemia,...
5776503 Amino acid solutions for treatment of peritoneal dialysis patients  
The present invention provides a dialysis solution that contains amino acids for treating and/or preventing malnutrition in a peritoneal dialysis patient. The amino acid composition is optimized to...
5770619 Method of activating photosensitive agents  
A method of administering photodynamic therapy begins with administering to an animal an effective amount of a photosensitizing agent which is less than about one half of the usual clinical dose...
5770622 Method of preserving materials using 4-methylene-2-amino-cyclopentane-1-carboxylic acids  
The invention relates to cyclopentane- and -pentene-β-amino acids, processes for their preparation and their use as medicaments, and to prevent contamination of materials such as wood and leather.
5767091 Analgesic effect enhancing preparations  
The present invention provides an analgesic effect enhancing preparation capable of enhancement of the effect of analgesics, the preparation comprising as an active ingredient the following amino...
5753254 Therapeutic agents containing thyroid hormones  
There is disclosed a solid fast dispersing dosage form of a pharmaceutical composition suitable for oral administration comprising: a therapeutic agent which comprises one or more compound thyroid...
5750558 Oxime derivatives of indole and indene compounds as inhibitors of prostaglandin biosynthesis  
Described herein are compounds having the formula ##STR1## or a pharmaceutically acceptable salt thereof wherein L is selected from the group consisting of ##STR2## R2 is selected from (a) ##STR3##...
5746998 Targeted co-polymers for radiographic imaging  
A radiographic imaging agent including a plurality of block copolymers forming a micelle, the block copolymers including a hydrophilic polymer linked to a hydrophobic polymer, and the hydrophobic...
5741817 Use of low molecular weight amino acids in ophthalmic compositions  
The use of glycine and other low molecular weight amino acids in ophthalmic compositions (e.g., preserved saline solutions) is described. These compounds have been found to enhance the efficacy of...
5739163 Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists  
This invention relates to novel compounds containing basic and acidic termini, pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using...
5739160 Cyclopentane- and -pentene-β-amino acids  
New Cyclopentane- or cyclopentene-beta-aminoacid derivatives and their isomers, acid additional salts and metal salt complexes have strong antimicrobial and broad-spectrum antimycotic acitivity. As...
5739164 Pharmaceutical compounds for the treatment of CNS diseases  
Disclosed herein is a method of treating a disease of the central nervous system with a compound of the formula ##STR1## in which m is 0, 1 or 2, n and q are each 0 or 1 to 5, and p is 0 or 1, X is...
5736563 Transcutaneous in vivo activation of photosensitive agents in blood  
A method destroys or impairs target cells that have selectively accumulated a photosensitizing agent. The target cells are in the bloodstream of an intact animal, which bloodstream and animal...
5733539 Bait for fishes and shellfishes  
The invention discloses a bait for fishes and shellfishes characterized in that the bait comprises a matrix material containing a microorganically fermented product of a plant residue obtained by...
5731349 Medicinal preparation of antistress, stess-protective and nootropic effect  
A pharmaceutical preparation of antistress, stress-protective and nootropic effect contains an effective substance represented by an amino-acid glycine or its pharmaceutically acceptable salt.A...
5731348 Alkylcarboxy amino acids-modulators of the kainate receptor  
Compounds of a new class of alkyl carboxy amino acid analogs of glutamic acid act as specific regulators of the kainic acid EAA receptor cation channel. These compounds are useful for treating...
5731290 Method of improving the immune response  
The invention provides diet supplements for pre-operative treatment of patients due for surgery.
5728675 Antemortem nutrient supplement for livestock  
The invention relates to an antemortem stress supplement for livestock containing one or more sources of electrolytes including sodium, potassium and magnesium, one or more sources of amino acids...
5728736 Reduction of hair growth  
Mammalian hair growth is reduced by applying to the skin a dermatologically acceptable composition including an inhibitor of arginase.
5728678 Method and composition for providing nutrition to a renal failure patient  
The present invention provides a composition as well as method for providing nutrition to renal patients. Pursuant to the present invention, the enteral composition includes an effective amount of...
5728683 External escinol preparation for skin  
An external preparation for skin comprising at least one member selected from the group consisting of escinol and its salts represented by the following constitutional formula (1): ##STR1##...
5723448 Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction  
Administration of argininosuccinate synthetase activity reducing agents, e.g., argininosuccinate synthetase induction blocking agents (e.g., antibiotics that bind to DNA sequences present in the...
5721278 Ovulation control by regulating nitric oxide levels  
Inhibition of ovulation in a female may be achieved by administering a nitric oxide synthase inhibitor, alone or in combination with one or more of a progestin, an estrogen, and an LH-RH...
5719119 Parenteral nutrition therapy with amino acids  
Parenteral nutrition aqueous solutions are provided which preferably contain glutamine together with other organic nitrogen containing compounds. The respective concentrations of the compounds...
5719133 Adolescent dietary composition  
A dietary composition comprising, based on total caloric content of the composition, a) a carbohydrate component which comprises from 50 to 65% of the total caloric content; b) a lipid component...
5719134 Method of providing nutrition to adolescents  
A dietary composition comprising, based on total caloric content of the composition, a) a carbohydrate component which comprises from 50 to 65% of the total caloric content; b) a lipid component...
5716976 Method of treatment for carbohydrate addiction  
A method is described for alleviating carbohydrate addiction by administration of anorexients on a schedule that avoids tolerance to the anorexient.
5690967 Compositions for improved topical delivery of lactic acid  
Compositions for improved topical delivery of lactic acid comprising lactic acid and an amphoteric or pseudoamphoteric agent.